First Sensor AG / Key word(s): Change in Forecast 14.10.2016 16:21 Disclosure of an inside information according to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- First Sensor's Shares: ISIN DE0007201907 Ι WKN (German Securities Identification Number) 720190 First Sensor AG raises guidance for EBIT margin following strong third quarter According to preliminary estimates for the third quarter of 2016, the Executive Board of First Sensor AG expects to exceed targets for the year as a whole. In the third quarter of 2016, sales are expected to amount to EUR38.8 million, which corresponds to a 9.6% increase year-on-year (EUR35.4 million). This resulted in sales of EUR114.7 million for the first nine months of the current fiscal year (previous year: EUR102.6 million). In the third quarter of 2016, the EBIT margin was above the planned target of 5% to 6% and reached around 7.4%. This equates to EBIT of EUR2.9 million in the third quarter of 2016 (previous year: -EUR0.7 million due to extraordinary effects). After the first nine months of 2016, EBIT was EUR8.4 million (previous year: EUR2.3 million) and the margin amounted to 7.3% overall. For the year as a whole, the Management Board had anticipated sales between EUR145 million and EUR150 million and an EBIT margin between 5% and 6%. Based on the latest estimate, sales are expected to fall within the planned range at year-end, while the EBIT margin is expected to be around one percentage point above the planned margin and amount to 6% to 7%. This positive development is the result of extensive efficiency improvements. The full quarterly report will be published on November 10, 2016. --------------------------------------------------------------------------- Information and Explanation of the Issuer to this News: About First Sensor AG First Sensor AG is one of the world's leading suppliers in the field of sensor systems. Our company develops and manufactures standardized and customized sensor solutions for applications in the Industrial, Medical and Mobility growth markets. With over 800 employees, we are represented at six German locations and also have development, production and sales sites in the USA, Canada, Singapore, China, the Netherlands, Great Britain, France, Sweden and Denmark along with a worldwide partner network. First Sensor AG is a German public limited company and has been listed in the Prime Standard of the German stock exchange in Frankfurt since 1999. For more details on First Sensor, please visit www.first-sensor.com. First Sensor AG contact: Peter-Behrens-Str. 15 Corinna Krause 12459 Berlin E-Mail: ir@first-sensor.com Deutschland T +49 30 639923-571 14.10.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: First Sensor AG Peter-Behrens-Straße 15 12459 Berlin Germany Phone: +49 (0)30 63 99 23-760 Fax: +49 (0)30 63 99 23-719 E-mail: ir@first-sensor.com Internet: www.first-sensor.com ISIN: DE0007201907 WKN: 720190 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: First Sensor AG: First Sensor AG raises
Top 10 Most Recent News Articles
World Young Scientist Summit 2026 in Wenzhou Kicks Off
Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...
Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026
The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...
Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies
Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...
Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness
A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...
Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle
Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...
Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese
Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...
Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study
Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...
Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans
NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...
Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil
Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...
Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial
Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...
Continue ReadingTop 5 Most Recently Viewed Articles
Pharma Equity Group's Journey Through H1 2025 Financials
Pharma Equity Group's Interim Report for First Half of 2025 Key Highlights of H1 2025 Recently, Pharma Equity Group A/S underwent a thorough review by its Board of Directors and Executive Board, affirming their progress and strategies during the first half of 2025. Strategic Developments In a significant strategic shift, Pharma Equity Group has launched a new growth...
Continue Reading
Euro Manganese Welcomes New Director to Enhance Leadership Team
Euro Manganese Inc. took a bold step back in 2024 when it brought on board Ms. Ludivine Wouters as a non-executive Director. This move was no ordinary appointment; it marked a significant shift in the company’s strategy as it aimed to solidify its presence in the battery materials sector, especially crucial for the electric vehicle (EV) industry. Strategic Shift: New...
Continue Reading
Gneuton Innovations: Revolutionizing Water Sustainability in AI
Gneuton Innovations in AI Data Centers Gneuton, a groundbreaking clean technology company, is making waves in the field of regenerative AI infrastructure. The company has recently introduced a unique deployable water purification system that operates within gas turbine-powered AI data centers. This innovative system utilizes a patented thermal distillation technique,...
Continue Reading
Transamerica Reinforces Leadership for Retirement Expansion
Transamerica's Next Phase: Leadership Moves in Retirement Transamerica just pulled a move that’s both bold and calculated. They’ve beefed up their retirement distribution squad with Danny Kling and Kevin Murphy stepping into the spotlight. These guys are bringing heaps of experience and a fresh jolt of energy to keep the momentum going. No doubt this is Transamerica...
Continue Reading
Unity Bancorp Drives Forward with Exciting Dividend Announcement
Unity Bancorp Declares Cash Dividend for Shareholders Unity Bancorp, Inc. (NASDAQ: UNTY), the parent company of Unity Bank, has made an exciting announcement regarding its commitment to rewarding shareholders. The company's Board of Directors has declared a cash dividend amounting to $0.15 per common share. This dividend, representing a positive sign for shareholders,...
Continue Reading